AEPFX | HNCTX | AEPFX / HNCTX | |
Total Expense Ratio | 0.58 | 1.00 | 58% |
Annual Report Gross Expense Ratio | 0.58 | 1.01 | 57% |
Fund Existence | 17 years | 19 years | - |
Gain YTD | 14.638 | 20.620 | 71% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 135B | 341M | 39,589% |
Annual Yield % from dividends | 0.87 | 0.29 | 302% |
Returns for 1 year | 10.06 | 24.18 | 42% |
Returns for 3 years | 32.51 | 59.43 | 55% |
Returns for 5 years | 17.85 | 33.65 | 53% |
Returns for 10 years | 35.74 | 69.18 | 52% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
SYNB | 29.78 | 0.19 | +0.66% |
Putnam BioRevolution ETF | |||
LQTI | 20.14 | 0.04 | +0.22% |
FT Vest Investment Grade & Target Income ETF | |||
AVIG | 41.37 | 0.09 | +0.21% |
Avantis Core Fixed Income ETF | |||
GNOV | 37.05 | 0.06 | +0.16% |
FT Vest U.S. Eq Mod Buffr ETF - Nov | |||
IBHJ | 26.55 | 0.03 | +0.13% |
iShares iBonds 2030 Term Hi Yld & IncETF |